Regulatory Updates
🇺🇸 FDA Page 29FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 337–348 of 373 articles
GCC-DR Harmonization Pharmaceutical Market: What You Need to Know
FDA Approves DermaClear: New Safe Option for Severe Acne Vulgaris
FDA Safety Labeling Changes: Impact on Antidepressant Market & Prescribing Trends 2026
FDA Accelerated Approvals 2026: Zongertinib and Oncology Policy Shifts
Medicare Coverage CAR-T Therapies: Policy Changes & Patient Impact 2024
FDA Biosimilar Substitution Policy Update: Key Regulatory Changes
FDA Accelerated Approvals Oncology: 2026 Policy Changes & Impact
FDA Updates Diabetes Therapy Label: Key Safety Warning Changes
FDA Approves AllerClear OTC: What You Need to Know
FDA Approves AI-Driven Drug ALGO-1 for Treatment-Resistant Depression
FDA Priority Review ArterioFlow: Accelerating PAD Treatment
FDA Approves Prevnar 20 Pediatric Indication Expansion for Pneumococcal Disease